CAS 987-24-6: Betamethasone acetate

BETAMETHASONE ACETATE CRS

Applications Betamethasone 21-Acetate-d3, is the labeled analogue of Betamethasone 21-Acetate (B327025), which is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties which can be used in treatment of asthma and itching. References Kerns, E., et al.: J. Pharm. Sci., 90, 1838 (2001), Seidler, J., et al.: J. Med. Chem., 46, 4477 (2003), Alsenz, J., et al.: J. Pharm. Sci., 96, 1748 (2007),

Betamethasone acetate, the 21-acetate ester of betamethasone, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester.

Halogenated derivatives of adrenal cortical hormones

Applications Betamethasone acetate (BA) is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties which can be used in treatment of asthma and itching. References Kerns, E., et al.: J. Pharm. Sci., 90, 1838 (2001), Seidler, J., et al.: J. Med. Chem., 46, 4477 (2003), Alsenz, J., et al.: J. Pharm. Sci., 96, 1748 (2007),

Betamethasone 21-acetate is a potent corticosteroid that is effective in the treatment of inflammatory conditions, such as asthma and arthritis. It also helps to reduce the symptoms of inflammatory skin diseases, including atopic dermatitis, contact dermatitis, and psoriasis. Betamethasone 21-acetate is used to treat perinatal complications such as preterm labor and neonatal respiratory distress syndrome. This drug has been shown to have a low cardiac effect when administered at a low dose (1 mg/kg). The stability of betamethasone 21-acetate in blood samples is increased by adding benzalkonium chloride or trifluoroacetic acid. Betamethasone 21-acetate has been shown to be absorbed rapidly from the gastrointestinal tract and distributed widely throughout the body. It binds to plasma proteins and has a short elimination half-life of 1.5 hours.